[1] |
TANAKA Y, CHEN Z J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway[J]. Sci Signal, 2012, 5(214):ra20.
|
[2] |
ISHIKAWA H, BARBER G N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling[J]. Nature, 2008, 455(7213):674-678.
|
[3] |
BARNETT K C, CORONAS-SERNA J M, ZHOU W, et al. Phosphoinositide interactions position cGAS at the plasma membrane to ensure efficient distinction between self- and viral DNA[J]. Cell, 2019, 176(6):1432-1446.
|
[4] |
KWON J, BAKHOUM S F. The cytosolic DNA-sensing cGAS-STING pathway in cancer[J]. Cancer Discov, 2020, 10(1):26-39.
|
[5] |
KONNO H, BARBER G N. The STING controlled cytosolic-DNA activated innate immune pathway and microbial disease[J]. Microbes Infect, 2014, 16(12):998-1001.
|
[6] |
DING L, HUANG X F, DONG G J, et al. Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal[J]. Biochim Biophys Acta, 2015, 1852(11):2494-2503.
|
[7] |
DANSAKO H, UEDA Y, OKUMURA N, et al. The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly[J]. FEBS J, 2016, 283(1):144-156.
|
[8] |
REINERT L S, LOPUŠNÁ K, WINTHER H, et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS[J]. Nat Commun, 2016, 7:13348.
|
[9] |
MA Z, DAMANIA B. The cGAS-STING defense pathway and its counteraction by viruses[J]. Cell Host Microbe, 2016, 19(2):150-158.
|
[10] |
SHAIKH M H, BORTNIK V, MCMILLAN N A, et al. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells[J]. Microb Pathog, 2019, 132:162-165.
|
[11] |
GAO D X, WU J X, WU Y T, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses[J]. Science, 2013, 341(6148):903-906.
|
[12] |
KARIMI-GOOGHERI M, DANESHVAR H, KHALEGHINIA M, et al. Decreased expressions of STING but not IRF3 molecules in chronic HBV infected patients[J]. Arch Iran Med, 2015, 18(6):351-354.
|
[13] |
ZHAO K, SONG D G, HE W Q, et al. Identification and phylogenetic analysis of an orf virus isolated from an outbreak in sheep in the Jilin province of China[J]. Vet Microbiol, 2010, 142(3-4):408-415.
|
[14] |
葛士坤, 张凯照, 鲁荣, 等. 2006-2016年中国羊口疮病毒的遗传演化分析[J]. 中国畜牧兽医, 2018, 45(2):439-447.GE S K, ZHANG K Z, LU R, et al. Genetic and phylogenetic analysis of Orf virus isolated in China from 2006 to 2016[J]. China Animal Husbandry & Veterinary Medicine, 2018, 45(2):439-447. (in Chinese)
|
[15] |
DEMIRASLAN H, DINC G, DOGANAY M. An overwiev of Orf virus infection in humans and animals[J]. Recent Pat Antiinfect Drug Discov, 2017, 12(1):21-30.
|
[16] |
王晴楠, 张凯照, 宁章勇. 我国1984-2014年羊口疮报道文献的统计分析[J]. 畜牧与兽医, 2015, 47(9):111-113.WANG Q N, ZHANG K Z, NING Z Y. Statistical analysis of reports on Orf in China from 1984 to 2014[J]. Animal Husbandry & Veterinary Medicine, 2015, 47(9):111-113. (in Chinese)
|
[17] |
TSAI S M, CHAN K W, HSU W L, et al. Development of a loop-mediated isothermal amplification for rapid detection of orf virus[J]. J Virol Methods, 2009, 157(2):200-204.
|
[18] |
NING Z Y, ZHENG Z W, HAO W B, et al. The N terminus of orf virus-encoded protein 002 inhibits acetylation of NF-κB p65 by preventing Ser276 phosphorylation[J]. PLoS One, 2013, 8(3):e58854.
|
[19] |
张彭涛, 刘健新, 李慧子, 等. 山羊STING和TBK1基因组织特异性表达和分布的研究[J]. 中国兽医科学, 2020, 50(8):1043-1049.ZHANG P T, LIU J X, LI H Z, et al. Tissue-specific expression pattern and histological distribution of STING and TBK1 in goat[J]. Chinese Veterinary Science, 2020, 50(8):1043-1049. (in Chinese)
|
[20] |
刘健新, 彭斐, 黎振标, 等. 山羊STING的克隆及其在OFTu细胞的表达[J]. 中国兽医学报, 2018, 38(5):1013-1018.LIU J X, PENG F, LI Z B, et al. Clone and expression of stimulator of interferon genes of goat in OFTu cells[J]. Chinese Journal of Veterinary Science, 2018, 38(5):1013-1018. (in Chinese)
|
[21] |
DALLAS A, JOHNSTON B H. Design and chemical modification of synthetic short shRNAs as potent RNAi triggers[J]. Methods Mol Biol, 2013, 942:279-290.
|
[22] |
汪园园, 童双, 李威, 等. 羊胚胎鼻甲细胞的原代培养及其在羊口疮病毒研究中的应用[J]. 中国兽医科学, 2013, 43(5):470-475.WANG Y Y, TONG S, LI W, et al. In vitro cultivation of primary ovine fetal turbinate cells its application in researches of ovine orf virus[J]. Chinese Veterinary Science, 2013, 43(5):470-475. (in Chinese)
|
[23] |
李显, 张富东, 张中旺, 等. 口蹄疫病毒利用自身蛋白逃逸宿主天然免疫应答的研究进展[J]. 畜牧兽医学报, 2020, 51(11):2622-2632.LI X, ZHANG F D, ZHANG Z W, et al. Recent advance on foot-and-mouth disease virus utilizes self-proteins to evade innate immunity response of host[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(11):2622-2632. (in Chinese)
|
[24] |
JANEWAY C A Jr. Pillars article:approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54:1-13[J]. J Immunol, 2013, 191(9):4475-4487.
|
[25] |
FLANNERY S, BOWIE A G. The interleukin-1 receptor-associated kinases:critical regulators of innate immune signalling[J]. Biochem Pharmacol, 2010, 80(12):1981-1991.
|
[26] |
AKIRA S, UEMATSU S, TAKEUCHI O. Pathogen recognition and innate immunity[J]. Cell, 2006, 124(4):783-801.
|
[27] |
SABBAH A, CHANG T H, HARNACK R, et al. Activation of innate immune antiviral responses by Nod2[J]. Nat Immunol, 2009, 10(10):1073-1080.
|
[28] |
ARNOULT D, SOARES F, TATTOLI I, et al. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix[J]. J Cell Sci, 2009, 122(Pt 17):3161-3168.
|
[29] |
GUO F, TANG L D, SHU S N, et al. Activation of stimulator of interferon genes in hepatocytes suppresses the replication of hepatitis B virus[J]. Antimicrob Agents Chemother, 2017, 61(10):e00771-17.
|
[30] |
FU Y Z, SU S, GAO Y Q, et al. Human cytomegalovirus tegument protein UL82 inhibits STING-mediated signaling to evade antiviral immunity[J]. Cell Host Microbe, 2017, 21(2):231-243.
|
[31] |
YAMASHIRO L H, WILSON S C, MORRISON H M, et al. Interferon-independent STING signaling promotes resistance to HSV-1in vivo[J]. Nat Commun, 2020, 11(1):3382.
|
[32] |
SCAGNOLARI C, CANNELLA F, PIERANGELI A, et al. Insights into the role of innate immunity in cervicovaginal papillomavirus infection from studies using gene-deficient mice[J]. J Virol, 2020, 94(12):e00087-20.
|